Sign in

Amani Alghalayini

@amanialghalayini.bsky.social
32 followers 61 following 5 posts

Biomedical scientist

PostsRepliesMedia
Reposted by Amani Alghalayini
Deborah Marsh @djmarsh24.bsky.social · 17/07/2026
A week of creativity in the lab - Part 1. Honours student Layal Dani supervised by @amanialghalayini.bsky.social was short-listed in our university’s microscopy imaging competition with her “Firework of Cancer Cells”. Congratulations to Layal who’s working on a microfluidics project 🧪 #ovariancancer
0112
Amani Alghalayini @amanialghalayini.bsky.social · 19/06/2026
📢 Expressions of Interest are now open for the Early Career Women in STEMM Grant & Paper Writing Workshop (ECWW2026), url.au.m.mimecastprotect.com/s/4DD5CQnMOq... #WomenInSTEMM #EarlyCareerResearchers #ResearchWriting #GrantWriting #AcademicDevelopment #STEMM #ResearchCareer
url.au.m.mimecastprotect.com
Early Career Women in STEMM Grant & Paper Writing Workshop
A workshop for Early Career Researchers to build on their scientific writing skills and gain inspiration from mentors and like-minded researchers. Learn more.
000
Amani Alghalayini @amanialghalayini.bsky.social · 12/06/2026
www.sydney.edu.au/medicine-hea... 🎉 Join the 2026 Early Career Women in STEMM Grant & Paper Writing Workshop! ✍️🌟 📅 28–30 Sept 2026 📍 Learning Studio 225, Susan Wakil Building, The University of Sydney Scientific writing, mentoring & career development. Save the date registrations coming soon!
sydney.edu.au
Early Career Women in STEMM Grant & Paper Writing Workshop
A workshop for Early Career Researchers to build on their scientific writing skills and gain inspiration from mentors and like-minded researchers. Learn more.
000
Reposted by Amani Alghalayini
Deborah Marsh @djmarsh24.bsky.social · 10/04/2026
Expanding the power of drugs used to treat liquid malignancies into solid tumours. We screened an epigenetic compound library against cell lines models of ovarian clear cell carcinoma. The BTK inhibitor ibrutinib shows promise #ovariancancer #ibrutinib 🧪 onlinelibrary.wiley.com/doi/epdf/10....
2235
Reposted by Amani Alghalayini
Deborah Marsh @djmarsh24.bsky.social · 08/12/2025
Comprehensive review out in December's Biomedicine & Pharmacotherapy from postdoc in my group @amanialghalayini.bsky.social - #GynaecologicalCancer #DrugRepurposing #GynaeCancers #OvarianCancer #EndometrialCancer #Organoids #3Rs #ClinicalTrials & more!! 🧪 www.sciencedirect.com/science/arti...
sciencedirect.com
Drug repurposing in gynaecological cancers: Proven drugs for new challenges
Gynaecological malignancies, including cervical, endometrial, ovarian, vaginal and vulval cancers, pose therapeutic challenges that contribute to this…
0185
Amani Alghalayini @amanialghalayini.bsky.social · 20/10/2025
Fantastic talk by Prof Alan D’Andrea (Dana-Farber Cancer Institute, Harvard Medical School) showing how the EWS-FLI1 fusion disrupts POLQ splicing and impairs the MMEJ DNA repair pathway in Ewing sarcoma @Australian Cell Cycle, DNA Repair, and Telomere Meeting 2025 #ACDTM25#CancerResearch
011
Amani Alghalayini @amanialghalayini.bsky.social · 14/08/2025
True cancer care must go beyond removing tumours. It must address the lasting scars, the fear of recurrence, and the need for ongoing support. Because survivorship is not just about living longer it is about living well. A powerful reminder from Prof. Bogda Koczwara at the #NSWcancersummit2025
020
Reposted by Amani Alghalayini
Deborah Marsh @djmarsh24.bsky.social · 08/03/2025
Early-career researcher @amanialghalayini.bsky.social from our group presenting her research in Canberra this week at the #ANZGOG2025ASM on in silico modelling & #DrugRepurposing to discover new ways to treat #ARID1A mutant #OvarianCancer. #ChromatinRemodelling #OvarianClearCellCarcinoma 🧪
031
Reposted by Amani Alghalayini
Gill Stannard @herbalgill.bsky.social · 07/03/2025
A pleasure to share the A Team's collaboration with researchers in the MRFF Drug Repurposing for Ovarian Cancer study at #Surv25 poster session.
042
Amani Alghalayini @amanialghalayini.bsky.social · 05/03/2025
Great talk from invited speaker Prof @djmarsh24.bsky.social at #ANZGOG2025 on ovarian cancer and ARID1A-related drug discovery
131